SHUTTLE PHARMACEUTICALS HOLD (SHPH) Stock Income Statement
NASDAQ:SHPH - Nasdaq - US8256933024 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 7.70M | 5.89M | 2.55M | 1.74M | 510.00K | |||
| Research and Development | 3.62M | 3.52M | 1.49M | 1.02M | 160.00K | |||
| Selling, General, and Administrative Expenses | 4.08M | 2.38M | 1.07M | 720.00K | 350.00K | |||
| Operating Income | -7.70M | -5.89M | -2.55M | -1.74M | -510.00K | |||
| Interest Income/Expense | -585.00K | -118.90K | -880.00K | 530.00K | -300.00K | |||
| Other Income/Expense | -30.20K | -104.30K | 330.00K | N/A | N/A | |||
| Non Recurring Items | -833.50K | -477.20K | 70.00K | 60.00K | 0.00 | |||
| Income Before Taxes | -9.14M | -6.59M | -3.03M | -1.15M | -810.00K | |||
| Income Tax | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Net Income | -9.14M | -6.59M | -3.10M | -1.26M | -910.00K | |||
| EBITDA | -7.69M | -5.89M | -2.54M | -1.73M | -500.00K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.19 | -3.54 | -0.23 | -0.09 | -0.07 | |||
| Statistics | ||||||||
All data in USD